Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Carroll & O'Dea
Article discusses public inquiries examining the adequacy of responses to multiple complaints about a medical practitioner.
Toby Mak
Supply of generic drugs and their interaction with the patent system, like standards essential patents, present one of the international frontiers of patent protection.
Singh & Associates
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
Singh & Associates
In the European Union (EU), 5 mg twice daily is the recommended dose for rheumatoid arthritis and psoriatic arthritis.
Singh & Associates
On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
Singh & Associates
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
Singh & Associates
Besremi was designated as an orphan medicinal product on December 09, 2011.
Nishith Desai Associates
January 01, 2019 marked the first anniversary of the Medical Device Rules 2017 – India's first step in de-linking medical devices regulations from drugs.
Singh & Associates
The WHO strategy for the influenza provides an outline a path to protect populations every year and helps prepare for a pandemic through strengthening routine programmes.
Singh & Associates
On March 19, 2019 the U.S. Food and Drug Administration approved Zulresso (brexanolone) intravenous (IV) formulation for the treatment of postpartum depression (PPD) in adult women.
Singh & Associates
This is the first and only treatment for nraxSpA approved by USFDA.
Singh & Associates
On Mar 20, 2019, World Health Organization issued guidelines "WHO Consolidated Guidelines on Drug- Resistant Tuberculosis Treatment" to accelerate the treatment of tuberculosis for proper eradication of the multidrug resistant TB ...
Singh & Associates
Earlier On 27th February, 2019, National Pharmaceuticals Pricing Authority (the ‘NPPA') listed 42 anti-cancer drugs under 30% Trade Margin rationalization.
Singh & Associates
On March 06, 2019, the Central Government proposed labeling specifications for import and manufacturing permission of New Drug Formulation under form 45/46 of Schedule A of Drugs and Cosmetics Act, 1940 ...
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Singh & Associates
Reported draft notification on revised Rules is based on recommendations of a panel set up by the ministry on August 04, 2018.
Singh & Associates
The review further concluded that there may be a link between the use of SGLT2 inhibitor and acute pancreatic.
Cyril Amarchand Mangaldas
India is currently facing a declining fertility rate and a changing social structure, with late marriages and single parenthood becoming more common.
Nishith Desai Associates
The pharmaceuticals and life sciences industry experienced an eventful 2018 because of numerous significant legal, regulatory and policy measures announced by the government in course of the year.
Khurana and Khurana
As a child growing up in India, or even as an adult, each one of us has had a fair experience of how grandmothers in Indian households peculiarly happen to have herbal prescriptions
Latest Video
Most Popular Recent Articles
NovoJuris Legal
The Personal Data Protection Bill, 2018 and the Data Protection Committee's Report (released on 27 July 2018) contains the framework and the policymakers' insight on protection of personal data in India.
Khurana and Khurana
The Hon'ble Delhi High Court has recently held that there is no deceptive similarity between the marks "Officer's Choice" and "Fauji" and has rejected Allied Blenders and Distillers Pvt Ltd's trademark infringement suit for its mark ‘Officer's Choice' against the owner of another alcoholic beverage, ‘Fauji'.
Vaish Associates Advocates
This case stands out because of total contrast in market definition between the majority and minority view of the Commission.
Davies Collison Cave
Key recent developments in the area of Technology, Media and Telecommunications are summarised below.
Duane Morris LLP
Any pharmaceutical product not being made in Indonesia must obtain a compulsory license, according to a recent new regulation adopted in Jakarta.
Davies Collison Cave
The only existing regulation relating to medical device software concerns software which is associated with physical devices.
Singh & Associates
In the European Union (EU), 5 mg twice daily is the recommended dose for rheumatoid arthritis and psoriatic arthritis.
Nishith Desai Associates
The pharmaceuticals and life sciences industry experienced an eventful 2018 because of numerous significant legal, regulatory and policy measures announced by the government in course of the year.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter